Frost & Sullivan Research Service   Published: 5 Nov 2008
U.S. PET and PET-CT Imaging Equipment Markets
  SERVICE HOMEPAGE
RESEARCH OVERVIEW LIST OF FIGURES TABLE OF CONTENTS
ORDERING INFORMATION FURTHER INFORMATION
   Research Overview
 

This Frost & Sullivan research service titled U.S. PET and PET-CT Imaging Equipment Markets provides an overview of the competitive structure, market share analysis, and revenues in the stand-alone positron emission tomography (PET) and PET-computed tomography (CT) scanner markets along with a complete analysis of key market drivers, restraints, and trends that are impacting the molecular medicine industry.

This analysis is available through our Medical Imaging Growth Partnership Services program. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services program ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.

Market Overview

U.S. PET and PET-CT Imaging Equipment Markets Rebound with Introduction of Novel Radiopharmaceutical Agents and Expanded FDG Coverage

The PET and PET-CT markets witnessed a significant drop in revenues and unit shipment during 2006-2007, recoiling from the impact of the Deficit Reduction Act (DRA). However, the markets recovered in 2008, stabilizing and registering a modest single digit growth rate. The market is technology-driven with add-on concepts continuing to determine the success quotient. Time-of-flight imaging has emerged ahead of the pack as the future of next generation imaging. Add-on technologies will drive increased uptake and procedure volume of PET-CT. The expansion of PET-CT into radiation treatment planning and therapeutic validation will trigger the sales of new equipment. "Technology is ready for futuristic healthcare; radiopharmaceuticals, however, continues to mature with little innovation seen in the industry," notes the analyst of this research service. "Significant growth is expected, nonetheless, with investments flooding into this area as radiotherapeutics and neurological diagnostic agents generate more buzz."

PET-CT has gained traction in the radiotherapy planning market and played a significant role in validating the effectiveness of radiotherapy treatment. It has proven immensely useful in a variety of channels encompassing breast cancer staging/management, and myocardial viability tests. Novel radiopharmaceutical agents developed for these emerging segments will drive PET-CT penetration in non-oncolologic applications and pave the way for additional revenue channels for both imaging providers and manufacturers. Apart from these factors, the expected expansion of Fluorodeoxyglucose (FDG) coverage into all oncologic indications will help the PET-CT market grow at a higher-than-expected growth. In spite of the launch of innovative technologies, regulatory hurdles and an inefficient approval process have remained major roadblocks for the implementation of new radiopharmaceuticals.

Efficiency and Cost-effectiveness Enable Deeper Penetration of PET and PET-CT

PET-CT can address growing public concern over the rising costs of healthcare. "Novel solid-state materials and other enabling technologies will act as springboards for delivering superior oncology imaging techniques," says the analyst. "Rapid innovation in two key market segments, radiotherapy planning and PET-magnetic resonance (MR) will enable physicians to deliver personalized medicine with greater efficiency and effectiveness than previously possible, leading to significant improvements in patient management and overall patient outcomes." Further, PET-CT continues to augment radiotherapy planning, particularly in validating therapy effectiveness in both existing and novel radiotherapy methods. As a result, physicians are now able to demonstrate and/or improve the cost-effectiveness of radiotherapy, ultimately resulting in a more efficient healthcare system.

As the technology gains widespread acceptance, PET-CT manufacturers must undertake total cost of ownership studies with early adopters, demonstrating the utility and cost-effectiveness of the technology. Manufacturers can utilize this data to proactively market productivity gains and cost savings to ensure that upgrade rates from stand-alone PET to PET-CT multiply. By 2010, positron emission mammography (PEM) and cardiac PET will entirely replace general-purpose stand-alone systems, ensuring positive growth in 2011.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

  • PET and PET-CT
  • FDG
  • Diagnostic and therapeutic radiopharmaceuticals

Technologies

The following technologies are covered in this research:

  • Stand-alone PET scanner
  • Fixed PET-CT scanner
  • Mobile PET-CT scanner
  • FDG
  • Diagnostic radiopharmaceuticals (cardiology, neurology, oncology)
  • Radiotherapeutics
  • Alphaimmunotherapy

Frost & Sullivan Growth Partnership Services

Frost & Sullivan's Growth Partnership Services empower companies to accelerate their growth by achieving top-line improvements and bottom-line results. This is accomplished by helping our clients execute successful growth strategies and providing their Growth Teams™ with the skills, know-how, and tools to generate growth opportunities, evaluate these opportunities to create a growth pipeline, and implement a growth strategy to deliver measurable business results.

Our growth solutions support the entire growth process:

TEAM Research is a program that furnishes clients with access to market research, competitive intelligence, financial benchmarking, and market strategies and analysis, and provides access to industry experts to aid in generating growth opportunities.

Growth Consulting Services unite clients with our industry experts to evaluate opportunities and develop customized strategies and business plans to drive top-line revenue and margin growth.

Growth Team Membership™ is a career-focused offering that was developed to address the unique challenges that senior executives face when implementing strategies to achieve aggressive corporate growth targets.

  Table Of Contents
  1 | EXECUTIVE SUMMARY
   Executive Summary
      1. Executive Summary

  2 | TOTAL PET AND PET-CT MARKETS
   Market Overview
      1. Introduction
      2. Scope and Segmentation
      3. Research Methodology
      4. Base Market Assumptions
      5. Forecast Methodology
      6. Restraints in Forecast

  Market Dynamics
      1. Measurements
      2. Industry Challenges
      3. Strategic Recommendations
      4. Market Drivers
      5. Market Restraints
      6. Revenue Forecasts

  Demand Analysis and Procedure Forecasts
      1. Unit Shipment Forecasts
      2. Installed Base Forecasts
      3. Procedure Volume Forecasts

  3 | STAND-ALONE PET MARKET
   Stand-alone PET Forecasts
      1. Overview
      2. Revenue Forecasts
      3. Unit Shipment Forecasts
      4. Pricing Trends
      5. Installed Base Forecasts

  4 | PET-CT MARKET
   PET-CT Forecasts
      1. Market Overview
      2. Revenue Forecasts
      3. Unit Shipment Forecasts
      4. Pricing Trends
      5. Installed Base Forecasts

  PET-CT Competitive Analysis
      1. Competitive Structure
      2. Market Share Analysis
      3. Product Analysis

  5 | DECISION SUPPORT DATABASE
   Decision Support Database
      1. Number of Hospitals
      2. Total Healthcare Expenditure
      3. Breast Cancer Incidence
      4. Lung Cancer Incidence
      5. Global Incidence Rate of Myocardial Infarction

   List of Figures
 

Chapter 2

  • Total PET and PET-CT Markets: Impact of Top Three Industry Challenges (U.S.), 2008-2014
  • Total PET and PET-CT Markets: Strategic Recommendations (U.S.), 2008-2014
  • Total PET and PET-CT Markets: Market Drivers Ranked in Order of Impact (U.S.), 2008-2014
  • Total PET and PET-CT Markets: Market Restraints Ranked in Order of Impact (U.S.), 2008-2014
  • Total PET and PET-CT Markets: Revenue Forecasts (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Revenues by Product Segment (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Percent of Revenues by Product Segment (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Revenues by Camera Mobility (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Percent of Revenues by Camera Mobility (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Unit Shipment Forecasts (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Unit Shipment by Purchase Type (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Installed Base Forecasts (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Installed Base by Product Segment (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Percentage of Installed Base by Product Segment (U.S.), 2004-2014
  • Total PET and PET-CT Markets: Procedure Volume Forecasts (U.S.), 2004-2014
  • Total FDG Market: Reimbursement Approvals Related to PET (U.S.), 2007

Chapter 3

  • Stand-alone PET Market: Revenue Forecasts (U.S.), 2004-2014
  • Stand-alone PET Market: Unit Shipment Forecasts (U.S.), 2004-2014
  • Stand-alone PET Market: Pricing Trend Forecasts (U.S.), 2004-2014
  • Stand-alone PET Market: Installed Base Forecasts (U.S.), 2004-2014

Chapter 4

  • PET-CT Market: Revenue Forecasts (U.S.), 2004-2014
  • PET-CT Market: Unit Shipment Forecasts (U.S.), 2004-2014
  • PET-CT Market: Pricing Trend Forecasts (U.S.), 2004-2014
  • PET-CT Market: Installed Base Forecasts (U.S.), 2004-2014
  • PET-CT Market: Competitive Structure (U.S.), 2007
  • Total Nuclear Medicine Equipment Market: Market Share Trends of Major Market Participants (North America), 2003-2007
  • PET-CT Market: Product Analysis – Existing Products (U.S.), 2007
  More Information
Please print out this form, complete your details and fax it to Frost & Sullivan:
Latin & North America:
Frost & Sullivan
Sales Department
7550 West Interstate 10
Suite 400
San Antonio
Texas 78229-5616. USA
Fax: 888.690.3329
Asia Pacific:
Frost & Sullivan
Sales Department
100 Beach Road
#29-01/11, Shaw Tower
Singapore 189702
SINGAPORE
Fax: +65 68900988
EMEA:
Frost & Sullivan
Sales Department
Sullivan House
4 Grosvenor Gardens
London SW1W 0DH. UK
Fax: +44(0) 1865 389 515
SERVICE INQUIRY


I would like information on:
U.S. PET and PET-CT Imaging Equipment Markets (N436-01-00-00-00)

YOUR DETAILS

Name Address
Title
Company
Telephone State/Province
Fax Zip/Postal Code
Email Country
Select the markets that interest you Tell us the services that interest you
Aerospace & Defense
Automotive & Transportation
Business & Financial Services
Career Research
Chemicals, Materials & Foods
Consumer Products
Education
Electronics and Security
Energy & Power Systems
Environment & Building Technologies
Healthcare
Industrial Automation
Information & Communication Tech.
Measurement & Instrumentation
Metals & Minerals
 
Growth Partnership Services
Growth Team Membership
Growth Strategy Dialogue
Growth Consulting
Growth Workshops
Events
Corporate Training & Development
Best Practices Research
Technical Research
Econometric Research
Market Engineering Research
Customer Research
Financial Benchmarking & Analysis
Stratecast: Telecoms Strategic Forecasting
Career Opportunities
Press Support Services
Comments: (For instance 'Please send me more information on...')

  Further Information

Enquiries from:
Africa:
Tel:+27 21 680 3260
Email: enquiries@frost.com

Enquiries from:
Asia Pacific:
Tel: +65 68900999
Email: apacfrost@frost.com
 
Enquiries from:
Europe:
Tel: +44 (0) 20 7343 8383
Email: enquiries@frost.com
Enquiries from:
Latin America:
Tel: +54 11 4777 1550
Email: myfrost.la@frost.com
 

Enquiries from:
Middle East and North Africa:
Tel: +971.4.4331.893
Email: meenquiries@frost.com

Enquiries from:
North America:
Tel:+1.877.GO.FROST (463.7678)
Email: enquiries@frost.com
 

Enquiries from:
South Asia:
Tel: +91 (0) 22 6160 6666
Email: safrost@frost.com




 
For a full list of our offices click here.
 
Conseq